CentoRx data

Eric Topol of The Cleveland Clinic Foundation and Robert Califf of Duke University presented follow-up data showing that the benefits conferred by use of CentoRx versus placebo widened at six months compared to the benefits conferred at 30 days.

Califf said the continued widening of the event rate curves at six months shift the clinical benefit and cost-benefit ratio markedly in